社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
奔雷钞票
IP属地:未知
+关注
帖子 · 3
帖子 · 3
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
奔雷钞票
奔雷钞票
·
2021-06-25
Your money your choice
非常抱歉,此主贴已删除
看
2,850
回复
1
点赞
3
编组 21备份 2
分享
举报
奔雷钞票
奔雷钞票
·
2021-06-25
Your money your choice
非常抱歉,此主贴已删除
看
1,729
回复
评论
点赞
2
编组 21备份 2
分享
举报
奔雷钞票
奔雷钞票
·
2021-06-25
Wow sounds good
Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来股价上涨,百健因阿尔茨海默氏症治疗批准下降</blockquote>
(Update: June 24, 2021 at 09:32 a.m. ET) Eli Lilly shares jumped over 8% in morning trading after th
Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来股价上涨,百健因阿尔茨海默氏症治疗批准下降</blockquote>
看
1,734
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3573117142777497","uuid":"3573117142777497","gmtCreate":1610023119289,"gmtModify":1624591898863,"name":"奔雷钞票","pinyin":"blcpbenleichaopiao","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/2c3d6fd1582e91af287ad0fd9636b62b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":68,"tweetSize":3,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖(非转发)","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":6,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":7,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.07.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.21%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":122107559,"gmtCreate":1624601742171,"gmtModify":1633950650871,"author":{"id":"3573117142777497","authorId":"3573117142777497","name":"奔雷钞票","avatar":"https://static.tigerbbs.com/2c3d6fd1582e91af287ad0fd9636b62b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573117142777497","authorIdStr":"3573117142777497"},"themes":[],"title":"","htmlText":"Your money your choice","listText":"Your money your choice","text":"Your money your choice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/122107559","repostId":"1137689091","repostType":4,"isVote":1,"tweetType":1,"viewCount":2850,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":122107628,"gmtCreate":1624601728064,"gmtModify":1633950651095,"author":{"id":"3573117142777497","authorId":"3573117142777497","name":"奔雷钞票","avatar":"https://static.tigerbbs.com/2c3d6fd1582e91af287ad0fd9636b62b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573117142777497","authorIdStr":"3573117142777497"},"themes":[],"title":"","htmlText":"Your money your choice","listText":"Your money your choice","text":"Your money your choice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122107628","repostId":"1137689091","repostType":4,"isVote":1,"tweetType":1,"viewCount":1729,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":122078444,"gmtCreate":1624590415888,"gmtModify":1633950817013,"author":{"id":"3573117142777497","authorId":"3573117142777497","name":"奔雷钞票","avatar":"https://static.tigerbbs.com/2c3d6fd1582e91af287ad0fd9636b62b","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573117142777497","authorIdStr":"3573117142777497"},"themes":[],"title":"","htmlText":"Wow sounds good","listText":"Wow sounds good","text":"Wow sounds good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122078444","repostId":"1113369372","repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohunote.com/m/news/1113369372?lang=zh_CN&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来股价上涨,百健因阿尔茨海默氏症治疗批准下降</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p><p><blockquote><i><b>(更新:美国东部时间 2021 年 6 月 24 日上午 09:32)</b></i></blockquote></p><p> Eli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p><p><blockquote>礼来公司股价在早盘交易中上涨超过 8%,此前该制药商表示,其阿尔茨海默氏症治疗获得了美国食品和药物管理局的突破性疗法认定。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p><p><blockquote></blockquote></p><p> The move is meant to expedite the development and review of the experimental treatment.</p><p><blockquote>此举旨在加快实验治疗的开发和审查。</blockquote></p><p> Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p><p><blockquote>竞争对手百健(Biogen)的自家药物于本月早些时候获得批准,该公司在盘前交易中下跌超过 6%。FDA因批准该药物而面临一些医生和科学家的批评。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来股价上涨,百健因阿尔茨海默氏症治疗批准下降</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval<blockquote>礼来股价上涨,百健因阿尔茨海默氏症治疗批准下降</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Wall Street Journal</strong><span class=\"h-time small\">2021-06-24 19:48</span>\n</p>\n</h4>\n</header>\n<article>\n<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p><p><blockquote><i><b>(更新:美国东部时间 2021 年 6 月 24 日上午 09:32)</b></i></blockquote></p><p> Eli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p><p><blockquote>礼来公司股价在早盘交易中上涨超过 8%,此前该制药商表示,其阿尔茨海默氏症治疗获得了美国食品和药物管理局的突破性疗法认定。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p><p><blockquote></blockquote></p><p> The move is meant to expedite the development and review of the experimental treatment.</p><p><blockquote>此举旨在加快实验治疗的开发和审查。</blockquote></p><p> Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p><p><blockquote>竞争对手百健(Biogen)的自家药物于本月早些时候获得批准,该公司在盘前交易中下跌超过 6%。FDA因批准该药物而面临一些医生和科学家的批评。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">The Wall Street Journal</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1,"symbols_score_info":{"LLY":0.9}},"isVote":1,"tweetType":1,"viewCount":1734,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}